ARTICLE | Company News
Pharmacyclics regains Lutrin rights
May 4, 2001 7:00 AM UTC
PCYC regained rights in Europe, Asia, and Latin America to its Lutrin motexafin lutetium photosensitizing agent to treat cancer from Nycomed Amersham (NYE; LSE:NAM). Rights to the compound, which is i...